Zack's Investment Research Reports on OPTIMIZERx: Initiates "Outperform" Rating
(firmenpresse) - ROCHESTER, MI -- (Marketwire) -- 09/28/11 -- OPTIMIZERx Corporation (OTCBB: OPRX) today announced Zack's Investment Research coverage of the company. The following summarizes the Outlook and entire report on OPTIMIZERx can be read in its entirety by clicking .
Zack's Investment Outlook on OPTIMIZERx (OPRX):
"OPTIMIZERx's SampleMD software, which was integrated into Allscripts' e-prescription system in late 2010, affords prescribers seamless access to a universe of sample vouchers and prescription co-pay coupons. Allscripts, with ~100k prescribers using its system, is the largest e-prescriber provider. SampleMD provides pharmaceutical companies a novel way to promote their drugs. OPRX receives revenue from manufacturers for every coupon that is printed or redeemed.
"With the launch still in its infancy, revenue has been modest but is expected to ramp as the user base expands and utilization grows. Business model is super scalable. OPRX runs very lean and should have sufficient cash/financing until reaching positive cash flow.
"We think OPRX could hit profitability by 2012. We are initiating with a $5.00 price target and Outperform rating."
OPTIMIZERx Corp. provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. For more information, please go to .
'SAFE HARBOR'
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
David Harrell
248.651.6568
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.09.2011 - 12:00 Uhr
Sprache: Deutsch
News-ID 70466
Anzahl Zeichen: 0
contact information:
Town:
ROCHESTER, MI
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Zack's Investment Research Reports on OPTIMIZERx: Initiates "Outperform" Rating"
steht unter der journalistisch-redaktionellen Verantwortung von
OPTIMIZERx Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
